Finance

Lists
NAGE:NASDAQ
Niagen Bioscience Inc
US$2,69
0,00%
(0,00) 1D
6 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NAGE...
Mkt. cap
214,54 ລ້ານ
Avg. vol.
474,27 ພັນ
Volume
109,00
52-wk high
US$7,95
52-wk low
US$2,62
Beta
2,02
Shares outstanding
79,13 ລ້ານ
No. of employees
117
Mkt. cap
214,54 ລ້ານ
Avg. vol.
474,27 ພັນ
Volume
109,00
52-wk high
US$7,95
52-wk low
US$2,62
Beta
2,02
Shares outstanding
79,13 ລ້ານ
No. of employees
117
News stories
From web sources and news partners
Profile
Niagen Bioscience, formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ. Wikipedia
About Niagen Bioscience Inc
CEO-
Employees117
Founded1999
Headquartersລອສ ແອງເຈີລີສ, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorPersonal care products
Websiteniagenbioscience.com
Analyst ratings
Based on 4 analysts giving stock ratings to NAGE in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for NAGE in the last 3 months.
Highest
Current US$2,69
US$11,00 (+308,92%)
Average
US$10,50 (+290,33%)
Lowest
US$10,00 (+271,75%)
Analyst
Recommendation
Action
Price target
Projected
Date
Susan Anderson
Canaccord Genuity
Buy
Reiterated
US$10,00
+271,7%
10/05/2026
Sean McGowan
Roth MKM
Buy
Maintained
US$10,00
+271,7%
08/05/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
US$11,00
+308,9%
08/05/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Maintained
US$11,00
+308,9%
07/21/2026
Ilya Zubkov
Freedom Capital Markets
Buy
Initiated
US$9,00
+234,6%
07/06/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Reiterated
US$12,00
+346,1%
05/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
33,99 ລ້ານ
33,84 ລ້ານ
31,47 ລ້ານ
29,78 ລ້ານ
Cost of goods sold
12,06 ລ້ານ
12,14 ລ້ານ
11,50 ລ້ານ
10,47 ລ້ານ
Cost of revenue
12,06 ລ້ານ
12,14 ລ້ານ
11,50 ລ້ານ
10,47 ລ້ານ
Research and development expenses
1,80 ລ້ານ
1,71 ລ້ານ
1,48 ລ້ານ
1,51 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15,90 ລ້ານ
17,89 ລ້ານ
16,92 ລ້ານ
17,10 ລ້ານ
Operating expense
17,69 ລ້ານ
19,60 ລ້ານ
18,40 ລ້ານ
18,61 ລ້ານ
Total operating expenses
29,75 ລ້ານ
31,74 ລ້ານ
29,90 ລ້ານ
29,08 ລ້ານ
Operating income
4,24 ລ້ານ
2,10 ລ້ານ
1,58 ລ້ານ
700,00 ພັນ
Other non operating income
-
-214,00 ພັນ
-
-
EBT including unusual items
4,80 ລ້ານ
4,42 ລ້ານ
6,74 ລ້ານ
1,07 ລ້ານ
EBT excluding unusual items
4,80 ລ້ານ
2,44 ລ້ານ
1,95 ລ້ານ
1,07 ລ້ານ
Income tax expense
222,00 ພັນ
292,00 ພັນ
417,00 ພັນ
106,00 ພັນ
Effective tax rate
4,62%
6,60%
6,19%
9,92%
Other operating expenses
-
-
-
-
Net income
4,58 ລ້ານ
4,13 ລ້ານ
6,32 ລ້ານ
963,00 ພັນ
Net profit margin
13,47%
12,21%
20,07%
3,23%
Earnings per share
0,05
0,03
0,02
0,01
Interest and investment income
564,00 ພັນ
552,00 ພັນ
375,00 ພັນ
372,00 ພັນ
Interest expense
-
-
-
-
Net interest expenses
564,00 ພັນ
552,00 ພັນ
375,00 ພັນ
372,00 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
4,43 ລ້ານ
2,30 ລ້ານ
1,87 ລ້ານ
991,00 ພັນ
Gain or loss from assets sale
-
-
-4,78 ລ້ານ
26,00 ພັນ
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
ແອັບຂອງ Google